Albuquerque, NM, 11 December, 2024 – Indica Labs, the global leader in AI-powered digital pathology, today announces that the Institute of Tissue Medicine and Pathology at the University of Bern, a leading university...

Deep Bio: An artificial intelligence-based prostate cancer diagnosis aid developed by a Korean company has received marketing authorization from overseas regulators, attracting the industry’s attention. Deep Bio said Tuesday that its...

Visiopharm: Join us on 5 September in Basel, Switzerland for our breakfast symposium at the 2022 European Congress of Pathology (ECP). Learn more about how existing manual processes in the histopathology lab can be optimized to introduce...

Paige now holds six CE marks in its portfolio of clinical AI applications Paige Breast Lymph Node was first launched at the United States and Canadian Academy of Pathology (USCAP) Annual Meeting in March 2022 NEW YORK--(BUSINESS...

Albuquerque, NM, 10 January, 2022 – Indica Labs, a leading provider of computational pathology software and services, is proud to announce that following ISO13485 certification, HALO AP® has received a CE Mark for use in primary diagnosis...

Artificial Intelligence technology shows promise in advancing pathology imaging, which can benefit cancer patients through more precise diagnosis leading to targeted treatment. Collaboration with PathAI expands pathologist access to...